RVTY vs SOLV — Key Metrics
| Metric | RVTY (REVVITY INC) | SOLV (SOLVENTUM CORP) |
|---|---|---|
| Price | 152.43 | 86.48 |
| Market Cap | 17.02 Billion | 14.68 Billion |
| P/E (TTM) | 67.75 | 97.17 |
| P/B (Quarterly) | 2.443 | 3.08 |
| P/S (TTM) | 5.78 | 1.8 |
| Net Profit Margin (TTM) | 8.6 | 1.9 |
| Gross Margin (TTM) | 55.9 | 54.8 |
| ROE (TTM) | 3.5 | 3.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Underperform
Outperform
Recommendation Summary
Stock RVTY is projected to underperform the market, stock SOLV is projected to outperform the market. Upfront Recommendation: SOLV.
Financial Metrics
| RVTY | Metrics | SOLV |
|---|---|---|
| $152.43 | Price | $86.48 |
| — | Market Capitalization | — |
| 67.75 | Price to Earnings Ratio | 97.17 |
| 5.78 | Price to Sales | 1.8 |
| 28.24 | Price to FCF Ratio | 47.65 |
| 10.35 | Price to Gross Profit | 3.28 |
| 79.84 | Price to R&D | 20.3 |
| 9.14 | Price to Current Assets | 3.98 |
RVTY vs SOLV at a glance
Revvity INC (RVTY) and Solventum Corp (SOLV) are both in the Healthcare sector. RVTY is the larger, at $17.0 billion in market value against $14.7 billion for SOLV, about 1.2 times the size.
On trailing-twelve-month figures, RVTY trades at 67.8 times trailing earnings and SOLV at 97.2; net profit margins are 8.6% and 1.9%.
The Upfront Investment model currently rates RVTY Underperform and SOLV Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.